Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83102912 | 8310291 | 2 | F | 20111018 | 20160823 | 20111223 | 20160916 | EXP | US-ROCHE-1023582 | ROCHE | 75.21 | YR | M | Y | 77.40000 | KG | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83102912 | 8310291 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MIN ON DAY1 AND DAY15 EVERY 28 DAYS?ALSO RECEIVED ON 07/OCT/2010, 02/DEC/2010, 29/DEC/201 | U | 125085 | 1466 | MG | SOLUTION FOR INFUSION | ||||||
| 83102912 | 8310291 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1408 | MG | SOLUTION FOR INFUSION | |||||||
| 83102912 | 8310291 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 1433 | MG | SOLUTION FOR INFUSION | |||||||
| 83102912 | 8310291 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 733 | MG | SOLUTION FOR INFUSION | |||||||
| 83102912 | 8310291 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | ALSO RECIEVED ON 14/JUL/2011, 11/AUG/2011, 08/SEP/2011, 06/OCT/2011 AND 17/NOV/2011 | U | 125085 | 1514 | MG | SOLUTION FOR INFUSION | ||||||
| 83102912 | 8310291 | 6 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAYS 1,8, 15, 22 EVERY 28 DAYS?ALSO RECIEVED ON 12/AUG/2010 | U | 0 | 45 | MG | |||||||
| 83102912 | 8310291 | 7 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 83102912 | 8310291 | 1 | Hepatocellular carcinoma |
| 83102912 | 8310291 | 6 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 83102912 | 8310291 | OT |
| 83102912 | 8310291 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 83102912 | 8310291 | Atrioventricular block complete | |
| 83102912 | 8310291 | Back pain | |
| 83102912 | 8310291 | Confusional state | |
| 83102912 | 8310291 | Dehydration | |
| 83102912 | 8310291 | Leukoencephalopathy | |
| 83102912 | 8310291 | Lymphocyte count decreased | |
| 83102912 | 8310291 | Mouth haemorrhage | |
| 83102912 | 8310291 | Neutrophil count decreased | |
| 83102912 | 8310291 | Platelet count decreased | |
| 83102912 | 8310291 | Urinary incontinence | |
| 83102912 | 8310291 | Urinary tract infection | |
| 83102912 | 8310291 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 83102912 | 8310291 | 1 | 20100708 | 0 | ||
| 83102912 | 8310291 | 2 | 20100812 | 0 | ||
| 83102912 | 8310291 | 3 | 20100909 | 0 | ||
| 83102912 | 8310291 | 4 | 20101103 | 0 | ||
| 83102912 | 8310291 | 5 | 20110616 | 0 | ||
| 83102912 | 8310291 | 6 | 20100708 | 0 | ||
| 83102912 | 8310291 | 7 | 20100909 | 0 |